Validated Chromatographic Methods for the Simultaneous Estimation of Etamsylate and Mefenamic Acid in the Presence of Their Main Impurities

Author(s): Asmaa Ahmed El-Zaher, Marianne Alphonse Mahrouse, Ahmed Mohammed Al-Ghani*.

Journal Name: Current Pharmaceutical Analysis

Volume 15 , Issue 6 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Etamsylate (ETS), a haemostatic drug, is formulated with mefenamic acid (MFA) for pain relief.

Objective: The aim of this work was to develop chromatographic methods for the estimation of ETS and MFA in the presence of their main impurities. These methods could be used in the routine analysis in quality control laboratories.

Methods: The first method was RP-HPLC method, the separation was carried out on an Inertsil® ODS- 3V C18 column using a mobile phase composed of acetonitrile: potassium dihydrogen phosphate buffer adjusted to pH 7 with 0.1 N NaOH (55: 45, v/v) at a flow rate of 1 ml/ min. The detection was carried out at 220 nm. The second method was a TLC-densitometric method where the studied components were separated using a developing system composed of dichloromethane: ethyl acetate: methanol: triethylamine (6: 2: 2: 0.5, v/v/v/v) on TLC silica gel 60 F254 plates, followed by densitometric scanning at 300 nm.

Results: In RP-HPLC method, the peaks were sharp and well separated, good retention times were obtained. Linearity was obtained over the concentration range 20-90 µg/ml, for both ETS and MFA. In the TLC-densitometric method, well separation of drug spots and linear relationship were achieved over the concentration range of 0.4-2.8 µg/spot, for both ETS and MFA. Method validation was conducted according to ICH guidelines.

Conclusion: The developed methods were applied for the determination of the cited drugs in laboratory prepared mixtures and in tablets containing the two drugs. The methods are simple and precise and can be used for routine analysis of the drugs in combined dosage forms in quality control laboratories.

Keywords: 2, 3-Dimethylaniline, etamsylate, hydroquinone, mefenamic acid, RP-HPLC, TLC-densitometric, validation.

[1]
Sweetman, S.C. Martindale: The complete drug reference, 36th ed; Pharmaceutical press, 2011.
[2]
G.B.S. Office U. K. S., '”British Pharmacopoeia; Stationery Office: London, 2016.
[3]
Kaul, N.; Agrawal, H.; Kakad, A.; Dhaneshwar, S.; Patil, B. Stress degradation studies on etamsylate using stability-indicating chromatographic methods. Anal. Chim. Acta, 2005, 53(1), 49-70.
[4]
Zivanovic, L.; Zecevic, M.; Markovic, S.; Petrovic, S.; Ivanovic, I. Validation of liquid chromatographic method for analysis of lidocaine hydrochloride, dexamethasone acetate, calcium dobesilate, buthylhydroxyanisol and degradation product hydroquinone in suppositories and ointment. J. Chromatogr. A, 2005, 1088(1), 182-186.
[5]
Vamshikrishna, N.; Shetty, A.S.K. Development and validation of RP-HPLC method for the estimation of ethamsylate in bulk drug and pharmaceutical formulations. Int. J. Chemtech Res., 2011, 3(2), 928-932.
[6]
Tolba, M. Simultaneous determination of some dihydroxy-benzenesulphonic acid derivatives and their degradation product and main impurity (hydroquinone) by ion‐pair liquid chromatography. J. Lumin., 2014, 29(7), 738-748.
[7]
El-Gindy, A.; Nassar, M.W.; Attia, K.A-S.; Abu-Seada, H.H.; El-Ghandour, M. High-performance liquid chromatographic determination of ethamsylate in human breast milk. J. Liq. Chromatogr. Relat. Technol., 2013, 36(14), 1915-1930.
[8]
El-Gindy, A.; Nassar, M.W.; Attia, K.A-S.; Abu-Seada, H.H.; El-Ghandour, M. High-performance liquid chromatographic determination of ethamsylate in urine and tablets. J. AOAC Int., 2013, 96(4), 730-736.
[9]
Helmy, S.A.; El Bedaiwy, H.M. A new and simple HPLC method for determination of etamsylate in human plasma and its application to pharmacokinetic study in healthy adult male volunteers. Saudi Pharm. J., 2013, 21(4), 405-410.
[10]
Shah, S.N.; Mirza, A.Z.; Shamshad, H.; Shafi, N.; Naz, M.A. Physical and chemical characterization of mefenamic acid in different pharmaceutical dosage forms and their stability studies using novel RP-HPLC method. Med. Chem. Res., 2012, 21(11), 3591-3597.
[11]
Dhumal, B.R.; Bhusari, K.P.; Tajne, M.R.; Ghante, M.H.; Jain, N.S. Stability indicating method for the determination of mefenamic acid in pharmaceutical formulations by HPLC. J. Appl. Pharm. Sci., 2014, 4(12), 60-64.
[12]
Srinivasa, R.A.; Pavankumar, K.L.N.N.S.V.K.; Satyanarayana, P.; Subrahmanya, S.G. Simultaneous estimation of mefenamic acid, ethamsylate and tranexamic acid in bulk and pharmaceutical formulations by RPHPLC method. Am. J. Pharmtech Res., 2015, 5(5), 402-414.
[13]
Morcoss, M.M.; Abdelwahab, N.S.; Ali, N.W.; Elsaady, M.T. Different chromatographic methods for simultaneous determination of mefenamic acid and two of its toxic impurities. J. Chromatogr. Sci., 2017, 55(7), 766-772.
[14]
Sato, J.; Owada, E.; Ito, K.; Niida, Y.; Wakamatsu, A.; Umetsu, M. Simple, rapid and sensitive reversed-phase high-performance liquid chromatographic method for the determination of mefenamic acid in plasma. J. Chromatogr. B Biomed. Sci. Appl., 1989, 493, 239-243.
[15]
Papadoyannis, I.N.; Samanidou, V.F.; Panopoulou, G.D. The use of bamifylline as internal standard in the reversed phase HPLC analysis of mefenamic acid in pharmaceuticals and small volumes of biological fluids. J. Liq. Chromatogr., 1992, 15(17), 3065-3085.
[16]
Poirier, J-M.; Lebot, M.; Cheymol, G. Rapid and sensitive liquid chromatographic assay of mefenamic acid in plasma. Ther. Drug Monit., 1992, 14, 322-326.
[17]
Mahadik, M.; Dhaneshwar, S.; Bhavsar, R. A high performance liquid chromatography-tandem mass spectrometric method for the determination of mefenamic acid in human plasma: application to pharmacokinetic study. Biomed. Chromatogr., 2012, 26(10), 1137-1142.
[18]
Uddin, A.; Mohamad, H.J.; Al-aama, M.; Amiruddin, N. High performance liquid chromatographic determination of mefenamic acid in human plasma using UV-VIS detector. Int. J. Pharm. Pharm. Sci., 2014, 6(11), 167-170.
[19]
Binhashim, N.H.; Hammami, M.M. A validated reversed phase HPLC assay for the determination of mefenamic acid in human plasma. Eur. J. Pharm. Med. Res., 2016, 3(7), 16-21.
[20]
Jaiswal, Y.; Talele, G.; Surana, S. Quantitative analysis of ethamsylate and mefenamic acid in tablets by use of planar chromatography. JPC-J. Planar Chromat., 2005, 18(106), 460-464.
[21]
Jaiswal, Y.; Talele, G.; Surana, S. Application of HPLC for the simultaneous determination of ethamsylate and mefenamic acid in bulk drugs and tablets. J. Liq. Chromatogr. Relat. Technol., 2007, 30(8), 1115-1124.
[22]
Ibrahim, F.; El-Din, M.K.S.; El-Deen, A.K.; Shimizu, K. Micellar HPLC method for simultaneous determination of ethamsylate and mefenamic acid in presence of their main impurities and degradation products. J. Chromatogr. Sci., 2016, 55(1), 23-29.
[23]
Branch, S.K. Guidelines from the international conference on harmonisation; ICH, 2005.
[24]
The United States Pharmacopeia. (USP 34), National Formulary (NF 29), 2011, Rockville, MD.


Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 15
ISSUE: 6
Year: 2019
Page: [624 - 631]
Pages: 8
DOI: 10.2174/1573412914666180423142911
Price: $65

Article Metrics

PDF: 40
HTML: 2
EPUB: 1
PRC: 1